NCT05474846View on ClinicalTrials.gov

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
SleepFatigueAnxietyCancerDepression
Interventions
DRUG

Melatonin

Given by PO

OTHER

Placebo for Melatonin

Given by PO

DRUG

Melatonin

Given by PO

DRUG

Methylphenidate

Given by PO

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER